Cited 26 times in
A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.